BioPharmSignal logoBioPharmSignal

Biotech News

Clover Health to Participate in Upcoming UBS Global Healthcare Conference

Clover Health (CLOV)Clover HealthConference / presentation

WILMINGTON, Del., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Financial Officer, Clay Thornton, will present at the 2026 UBS Global Healthcare Conference on Monday, November 9,

Related news

CLOVClover Health2026-02-17 21:05 EST

Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference

CLOVClover Health2026-07-22 20:05 EST

Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference

View all latest news

Clover Health

Medicare Advantage Clover Health operates a wide-network Medicare Advantage plan designed to improve access and outcomes for older adults, including populations that have historically lacked affordable, high-quality care. Clover Assistant Its clinical model is powered by Clover Assistant, an AI-enabled software platform that aggregates...

Recent company news

CLOVClover Health2026-11-04 21:05 EST

Clover Health Reports Third Quarter 2026 Results

CLOVClover Health2026-10-26 20:05 EST

Clover Health to Participate in Upcoming UBS Global Healthcare Conference

CLOVClover Health2026-10-19 20:30 EST

Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States

CLOVClover Health2026-10-08 22:45 EST

Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027

CLOVClover Health2026-10-07 20:05 EST

Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026

Stock data

Close
4.48 USD
Market cap
1.96B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States